Drug profile · INN
toremifene
FARESTON
toremifene (FARESTON) is a estrogen receptor modulator. Associated with Orion Laboratories Pty..
EMA: approved TGA: approved Antineoplastic and immunomodulating agents (L02) L02BA02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — toremifene
- Class
- Antineoplastic and immunomodulating agents (L02)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
toremifene (FARESTON) is a estrogen receptor modulator. Associated with Orion Laboratories Pty..
Key facts
INN toremifene
Brand FARESTON
Mechanism Estrogen receptor modulator
Therapeutic class Antineoplastic and immunomodulating agents (L02)
ATC code L02BA02
Originator Orion Laboratories Pty.
Mechanism of action
Estrogen receptor modulator
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is toremifene?
toremifene (FARESTON) is a estrogen receptor modulator. Associated with Orion Laboratories Pty..
What is the brand name for toremifene?
FARESTON is a marketed brand name for toremifene. Check FDA Drugs@FDA for the current US label holder and prescribing information.